Mar 07, 2014 at 15:27 | Source: CNBC-TV18
Biocon CMD Kiran Mazumdar-Shaw said the companys research efforts are focused on a number of programs that deliver drugs that women can benefit from.
Mar 06, 2014 at 19:45 | Source: Reuters
An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them, two senior government officials said last month.
Mar 06, 2014 at 16:04 | Source: Moneycontrol.com
Lupin has received final approval for its Doxycycline Capsules USP, 50 mg, 75 mg, and 100 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Aqua Pharmaceuticals Monodox Capsules 50 mg, 75 mg, and 100 mg. The Company also received final approval from the FDA for its Ciprofloxacin for Oral Suspension.
Mar 05, 2014 at 21:52 | Source: CNBC-TV18
Launching a new drug in India, whether a completely new molecule or a generic one, has become a herculean task. The Supreme Court's recent dictat that the government review 157 clinical trials has delayed fresh approvals.
Mar 05, 2014 at 15:23 | Source: PTI
Avelox (moxifloxacin HCl) tablets had a sales figure of approximately USD 195 millions in 2013: IMS Health
Mar 04, 2014 at 13:57 | Source: Moneycontrol.com
With reference to increase in the share prices of the Company across the Exchanges in the recent past, Parenteral Drugs India has clarified that the present situation in the prices of the shares of the Company is due to the market forces and not because of the reason known to the management of the Company.
Mar 04, 2014 at 12:05 | Source: Moneycontrol.com
The two hospitals are based in West Bengal-Kalpataru in Barasat and Rabindranath Thakur in Berhampore.
Mar 03, 2014 at 20:46 | Source: CNBC-TV18
Ireland drug maker Actavis (Watson) has also been sued by Sanofi for its generic application along with Glenmark.
Feb 28, 2014 at 22:11 | Source: CNBC-TV18
India is ahead of other EMs in innovation: Rogerio
Feb 28, 2014 at 15:25 | Source: Moneycontrol.com
Venus Remedies has already received patents for Elores from 46 countries. The drug was launched in India in January 2013.